cenerimod: Clinical Trials

4 trials of cenerimod, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 enrolling by invitation, 1 recruiting. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Active not recruiting 2, Enrolling by invitation 1, Recruiting 1

Follow cenerimod: new trials by email Literature Review of cenerimod trials Research Report on cenerimod

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Cenerimod, Placebo - Nephritis, Lupus, Lupus Erythematosus, Systemic
Phase 3RecruitingViatris Innovation GmbH3002026-02-092026-07-30
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Cenerimod - Lupus Erythematosus, Systemic
Phase 3Enrolling by invitationViatris Innovation GmbH6802024-07-302026-09-11
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
Cenerimod, Placebo - Lupus Erythematosus, Systemic
Phase 3Active not recruitingViatris Innovation GmbH4512023-06-262026-10-30
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
Cenerimod, Placebo - Lupus Erythematosus, Systemic
Phase 3Active not recruitingViatris Innovation GmbH4702022-12-132026-10-30

Conditions studied

Lupus Erythematosus, Systemic (4)  ·  Autoimmune Diseases (3)  ·  Connective Tissue Diseases (3)  ·  Immune System Diseases (3)  ·  Lupus Nephritis (1)  ·  Skin and Connective Tissue Diseases (1)

Sponsors

Viatris Innovation GmbH (4)

Countries

United States (4)  ·  Mexico (3)  ·  Philippines (3)  ·  Poland (3)  ·  Ukraine (3)  ·  Argentina (2)  ·  Brazil (2)  ·  Bulgaria (2)  ·  Chile (2)  ·  Colombia (2)  ·  Czechia (2)  ·  France (2)  ·  Georgia (2)  ·  Germany (2)  ·  Greece (2)

Results publications

PMID 39586304